Adoptive cellular gene therapy of autoimmune disease

Autoimmunity Reviews

Volumn 1, Issue 4, 2002, Pages 213-219

  Slavin, Anthony J ^a   Tarner, Ingo H ^a   Nakajima, Atsuo ^a   Urbanek Ruiz, Irene ^a   McBride, Jacqueline ^a   Contag, Christopher H ^a   Fathman, C Garrison ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritis; Autoimmunity; Diabetes; EAE; EAE, experimental autoimmune encephalomyelitis; Gene therapy; IRES, internal ribosome entry site; MBP, myelin basic protein; Th1, T helper type 1; Th2, T helper type 2; YFP, yellow fluorescent protein

Indexed keywords

ANTIINFLAMMATORY AGENT; CHIMERIC PROTEIN; COLLAGEN TYPE 2; DRUG VEHICLE; GAMMA INTERFERON RECEPTOR ANTAGONIST; INTERFERON GAMMA RECEPTOR IMMUNOGLOBULIN G PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR ANTAGONIST; INTERLEUKIN 4; INTERLEUKIN 4 IMMUNOGLOBULIN G1 PROTEIN; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN ANTIBODY; PROTEIN P40; RETROVIRUS VECTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ARTHRITIS; AUTOIMMUNE DISEASE; BIOLUMINESCENCE; CELL BASED GENE THERAPY; DENDRITIC CELL; DIABETES MELLITUS; ENCEPHALOMYELITIS; GENE EXPRESSION; GENE TRANSFER; HASHIMOTO DISEASE; HUMAN; IMAGING SYSTEM; IMMUNE RESPONSE; IMMUNOMODULATION; MULTIPLE SCLEROSIS; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; GENE THERAPY; GENE VECTOR; GENETICS; IMMUNOLOGY; LUMINESCENCE; METHODOLOGY; MOUSE; RETROVIRUS;

ADOPTIVE TRANSFER; ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE THERAPY; GENETIC VECTORS; LUMINESCENT MEASUREMENTS; MICE; RETROVIRIDAE;

EID: 0041968601     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(02)00051-4     Document Type: Review

References (36)

1. Harrison L.C., Hafler D.A. Antigen-specific therapy for autoimmune disease. Curr Opin Immunol. 12:2000;704-711.
2. Horsfall A.C., Butler M.D., Marinova L., et al. Suppresion of collagen induced arthritis by continuous administration of IL-4. J Immunol. 159:1997;5687-5696.
3. Garcia G., Komagata Y., Slavin A.J., Maron R., Weiner H.L. Suppression of collagen induced arthritis by oral or nasal administration of collagen II. J Autoimmunity. 13:1999;315-324.
4. Racke M.K., Bonomo A., Scott D.E., et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med. 180:1994;1961-1966.
5. Inobe J., Slavin A.J., Komagata Y., Chen Y., Liu L., Weiner H.L. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol. 28:1998;2780-2790.
6. Tominaga Y., Nagata M., Yasuda H., et al. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clin Immunol Immunopathol. 86:1998;209-218.
7. Leach M.W., Snyder E.A., Sinha D.P., Rosenblum I.Y. Safety evaluation of recombinant human interleukin-4. I. Preclinical studies. Clin Immunol Immunopathol. 83:1997;8-11.
8. Tarner I.H., Fathman C.G. Gene therapy in autoimmune disease. Curr Opin Immunol. 13:2001;676-682.
9. Nakajima A., Seroogy C.M., Sandora M.R., et al. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest. 107:2001;1293-1301.
10. Tuohy V.K., Mathisen P.M. T cell design for therapy in autoimmune demyelinating disease. J Neuroimmunol. 107:2000;226-232.
11. Rabinovich G.A., Daly G., Dreja H., et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med. 190:1999;385-398.
12. Kim S.H., Kim S., Evans C.H., Ghivizzani S.C., Oligino T., Robbins P.D. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol. 166:2001;3499-3505.
13. Morita Y., Yang J., Gupta R., et al. Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest. 107:2001;1275-1284.
14. Smaglik P. Gene therapy institute denies that errors led to trial death. Nature. 403:2000;820.
15. Costa G.L., Benson J.M., Seroogy C.M., Achacoso P., Fathman C.G., Nolan G.P. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J Immunol. 164:2000;3581-3590.
16. Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 288:2000;669-672.
17. Mulligan R.C. The basic science of gene therapy. Science. 260:1993;926-932.
18. Mann R., Mulligan R.C., Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell. 33:1983;153-159.
19. Costa G.L., Sandora M.R., Nakajima A., et al. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol. 167:2001;2379-2387.
20. Cottard V., Mulleman D., Bouille P., Mezzina M., Boissier M.C., Bessis N. Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis. Gene Ther. 7:2000;1930-1939.
21. Martino G., Poliani P.L., Furlan R., et al. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach. J Neuroimmunol. 107:2000;184-190.
22. Chang Y., Prud'homme G.J. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity. J Gene Med. 1:1999;415-423.
23. Batteux F., Trebeden H., Charreire J., Chiocchia G. Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin-10. Eur J Immunol. 29:1999;958-963.
24. Whalen J.D., Lechman E.L., Carlos C.A., et al. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol. 162:1999;3625-3632.
25. Bessis N., Chiocchia G., Kollias G., et al. Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10, or IL-13. Clin Exp Immunol. 111:1998;391-396.
26. Quattrocchi E., Walmsley M., Browne K., et al. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis. J Immunol. 163:1999;1000-1009.
27. Lawson B.R., Prud'homme G.J., Chang Y., et al. Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. J Clin Invest. 106:2000;207-215.
28. Shaw M.K., Lorens J.B., Dhawan A., et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med. 185:1997;1711-1714.
29. Mathisen P.M., Yu M., Johnson J.M., Drazba J.A., Tuohy V.K. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T-cells. J Exp Med. 186:1997;159-164.
30. Edinger M., Sweeney T.J., Tucker A.A., Olomu A.B., Negrin R.S., Contag C.H. Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia. 1:1999;303-310.
31. Contag C.H., Contag P.R., Mullins J.I., Spilman S.D., Stevenson D.K., Benaron D.A. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol. 18:1995;593-603.
32. Menges M., Rossner S., Voigtlander C., et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med. 195:2002;15-21.
33. Anderson W.F., McGarrity G.J., Moen R.C. Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays. Hum Gene Ther. 4:February 17, 1993;311-321.
34. Miller A.D. Human gene therapy comes of age. Nature. 357:1992;455-460.
35. Evans C.H., Ghivizzani S.C., Herndon J.H., Wasko M.C., Reinecke J., Wehling P., Robbins P.D. Clinical trials in the gene therapy of arthritis. Clin Orthop. 2000:2000;S300-S307.
36. Robbins P.D., Evans C.H., Chernajovsky Y. Gene therapy for rheumatoid arthritis. Springer Semin Immunopathol. 20:1998;197-209.